UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000038104
Receipt No. R000042859
Scientific Title A randomized non-inferiority controlled trial of postoperative analgesic effect of epidural anesthesia and rectus sheath block in laparoscopic surgery
Date of disclosure of the study information 2019/09/26
Last modified on 2022/04/06 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A randomized non-inferiority controlled trial of postoperative analgesic effect of epidural anesthesia and rectus sheath block in laparoscopic surgery
Acronym A randomized non-inferiority controlled trial of postoperative analgesic effect of epidural anesthesia and rectus sheath block in laparoscopic surgery
Scientific Title A randomized non-inferiority controlled trial of postoperative analgesic effect of epidural anesthesia and rectus sheath block in laparoscopic surgery
Scientific Title:Acronym A randomized non-inferiority controlled trial of postoperative analgesic effect of epidural anesthesia and rectus sheath block in laparoscopic surgery
Region
Japan

Condition
Condition Patients who received either laparoscopic gastrectomy or laparoscopic colectomy.
Classification by specialty
Gastrointestinal surgery Anesthesiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The purpose is to examine whether a single rectus sheath block is not inferior to continuous epidural anesthesia as postoperative analgesia for patients who have undergone either laparoscopic gastrectomy or laparoscopic colectomy.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Pain scale (Numerical Rating Scale) when coughing 24 hours after surgery
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification YES
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine Maneuver
Interventions/Control_1 Epidural anesthesia group
Before inducing anesthesia, perform catheter placement at the 9th to 11th thoracic vertebrae levels.
Administer 0.375% ropivacaine epidurally at the start of wound closure.
Patient-controlled epidural analgesia (PCEA) starts at the end of surgery. The drug solution is 0.2% Anapain and 3 mcg / mL fentanyl. Settings: Dosing rate 4 mL / h, bolus administration 2 mL, dosing interval 15 minutes or more, maximum one-time bolus administration 4 times.
Interventions/Control_2 Rectus sheath block group
After the introduction of anesthesia, before the start of surgery. At the umbilical level, 15 mL of 0.375% Anapane is administered under echo guide.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria Patients scheduled to undergo laparoscopic gastrectomy or laparoscopic colorectal resection of 6 cm or less where the wound is continuous with the umbilicus in addition to the port hole.
Age: 20 years old and younger than 80 years old at the time of obtaining consent
ASA-PS (American Society of Anesthesiologists physical status): 1-3
Patients who have received sufficient explanation for participation in this study, and who have fully understood and agreed to the document by their own will.
Key exclusion criteria Antiplatelet / anticoagulant therapy
There is a decrease in platelet count (80,000 <mcL), blood coagulation ability abnormality (aPTT> control value + 10 seconds or PT (%) <50%)
History of spine surgery
There is an allergy to the anesthetic used
Weight less than 40 kg
BMI> 30 kg / m2
Patients whose pain is difficult to evaluate (psycho-neuropathy, dementia, restlessness, etc.)
Use regular painkillers
Liver dysfunction (AST or ALT> 100 IU / L)
Renal dysfunction (eGFR <50 mL / min / 1.73m2)
Target sample size 80

Research contact person
Name of lead principal investigator
1st name Yohei
Middle name
Last name Owada
Organization University of Tsukuba
Division name Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery
Zip code 305-8576
Address 2-1-1 Amakubo, Tsukuba, Ibaraki
TEL 029-853-3221
Email y.owada@md.tsukuba.ac.jp

Public contact
Name of contact person
1st name Yohei
Middle name
Last name Owada
Organization University of Tsukuba
Division name Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery
Zip code 305-8575
Address 1-1-1 Tennodai, Tsukuba, Ibaraki
TEL 029-853-3221
Homepage URL
Email y.owada@md.tsukuba.ac.jp

Sponsor
Institute University of Tsukuba
Institute
Department

Funding Source
Organization Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Faculty of Medicine, University of Tsukuba
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Tsukuba Clinical Research & Development Organization
Address 2-1-1 Amakubo, Tsukuba, Ibaraki
Tel 029-853-3914
Email t-credo.adm@un.tsukuba.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 09 Month 26 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 80
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 09 Month 18 Day
Date of IRB
2019 Year 10 Month 10 Day
Anticipated trial start date
2019 Year 10 Month 01 Day
Last follow-up date
2021 Year 05 Month 16 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 09 Month 26 Day
Last modified on
2022 Year 04 Month 06 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000042859